The drug giant Reckitt Benckiser was ordered on Monday to pull some of its popular Nurofen painkiller brands off shelves in Australia after a court ruled it had made misleading claims.<br />The company has admitted to selling identical products that were marketed to treat specific types of pain, and for almost double the price of its standard painkiller.<br />The court ordered that Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain and Nurofen Tension Headache be removed from retail shelves within three months.
